Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Gastrointestinal Neoplasms 1Gastroesophageal Reflux 1Barrett Esophagus 1

Interventions

Endoscopy 13Endoscopy, Digestive System 12Radiofrequency Ablation 7Esomeprazole 7Biopsy 7Endoscopic Mucosal Resection 6Specimen Handling 4Proflavine 4Omeprazole 4Aspirin 4Gastroscopy 3YF 476 2Proton Pump Inhibitors 2Photochemotherapy 2Narrow Band Imaging 2Microscopy, Confocal 2Metformin 2Lansoprazole 2Itraconazole 2Endoscopes 2Diagnostic Imaging 2Dexlansoprazole 2Cryotherapy 2Cryosurgery 2Breath Tests 22-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2rofecoxib 1polyphenon E 1plecanatide 1omeprazole, sodium bicarbonate drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Barrett Esophagus × plecanatide × Clear all
NCT05107219 2026-04-07

GCC Agonist Signal in the Small Intestine

University of Wisconsin, Madison

Phase 1 Completed
43 enrolled
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux, Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡